Blueprint Genetics is a genetic testing company based in Helsinki, Seattle, and Dubai, with a customer base spanning over 70 countries. They provide world-class genetic diagnostics and clinical interpretation for rare inherited diseases in 14 medical specialties.

Blueprint Genetics does high quality genetics testing for a global clinical community. By combining a state-of-the-art laboratory process, the latest sequencing technology, AI empowered data-crunching tools and techniques, world-class professionals, and a holistic customer experience approach, they are leading the way in changing mainstream healthcare of tomorrow.

Blueprint Genetics was founded in 2012 as a Stanford University spin-off company, and acquired by Quest Diagnostics in 2020.